Open access
78
Views
7
CrossRef citations to date
0
Altmetric
Review
Comparison of extended release GLP-1 receptor agonist therapy versus sitagliptin in the management of type 2 diabetes
Mark W Stolar1 Clinical Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USACorrespondence[email protected]
, Michael Grimm2 Amylin Pharmaceuticals, LLC, San Diego, CA, USA
& Steve Chen2 Amylin Pharmaceuticals, LLC, San Diego, CA, USA
Pages 435-444
|
Published online: 22 Nov 2013
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.